38 results

CVD-MTE-Slider
Cardio

Posted on 27.05.2021

The need for an EU Action Plan for better cardiovascular health

Did you know that every day, some 5,000 people die from cardiovascular diseases (CVDs), amounting to 1.8 million deaths every year? This, unfortunately, makes cardiovascular disease – including heart failure, stroke-related atrial fibrillation, heart valve disease and coronary heart disease – the number one killer in Europe.  The COVID-19 pandemic has radically changed the way we […]

By Jean-Luc Lemercier Corporate Vice President Edwards Lifesciences, EMEA, Canada and Latin America & Chair of the Cardiovascular Sector Group of MedTech Europe

shutterstock_1357664711
COVID-19

Posted on 26.10.2020

COPD & COVID-19: Pandemic must prompt shift to connected care

For people living with chronic obstructive pulmonary disease (COPD), a long-term lung illness, COVID-19 is having a major impact. The pandemic has disrupted traditional models of care and put vulnerable patients at risk. Keeping patients out of hospital – by reducing scheduled visits and avoiding emergency admissions – has become the top priority.  A silver […]

By Odile Bigaignon Vice President, EMEA Marketing at ResMed

shutterstock_1686020212
COVID-19

Posted on 20.10.2020

In crisis, medtech found the path to realise its full potential

I have been truly humbled by the collective response of the medical technology industry through this pandemic. As we approach MedTech Week 2020, our industry can be proud of the contribution we have made. But as we reflect on the impact of this unprecedented year, perhaps the true legacy has yet to reveal itself: how […]

By Eric Thépaut Senior Vice President and President, EMEA - Boston Scientific

shutterstock_1323264992
COVID-19

Posted on 29.09.2020

Your heart has never been more important

The unprecedented COVID-19 has fundamentally shifted society’s and government’s attention and prioritisation of healthcare. Never has health topped our agenda as much as today – as an individual trying to stay healthy, as healthcare professional and facility trying to deliver a high quality of care, as industry trying to deliver the best innovations to improve […]

By Jean-Luc Lemercier Corporate Vice President Edwards Lifesciences, EMEA, Canada and Latin America & Chair of the Cardiovascular Sector Group of MedTech Europe

shutterstock_262883918
COVID-19

Posted on 27.08.2020

COVID-19 & diagnostics: the value of ‘test, test, test’

The power of diagnostics information (VODI) to public health and society was a topic of keen interest even before the COVID-19 outbreak. The pandemic offers us fresh lessons on how health systems can harness this value.  Many of us will recall one of the earliest recommendation from the Director General of the WHO during the […]

By Hans Martens Chair of the Coalition for Health, Ethics and Society (CHES), and former CEO of the European Policy Centre (EPC)

shutterstock_1512270797
Cardio

Posted on 17.12.2019

The 3 ways in which the EU can improve peoples’ heart health

Even in 2019, cardiovascular diseases (CVD) remain the number 1 killer globally, accounting for almost 2 million deaths in the EU alone every year. These diseases are linked to huge inequalities, with more cardiovascular-related deaths in women than men, and more CVD-related deaths in middle-income than high-income countries, as a recent study from the European […]

By Jean-Luc Lemercier Corporate Vice President Edwards Lifesciences, EMEA, Canada and Latin America & Chair of the Cardiovascular Sector Group of MedTech Europe

shutterstock_124539028
Value

Posted on 05.12.2019

Millions of patients suffering with AF may be missing out on a life-saving procedure

Our recently published report examining the available treatment options for Atrial Fibrillation (AF) across Europe has found that millions of patients suffering with the condition don’t have access to a potentially life-saving treatment — catheter ablation therapy. Currently, 11 million people in Europe are affected by AF, a condition characterized by an irregular and often […]

By Alenka Brzulja Vice President of Cardiovascular & Specialty Solutions EMEA, Johnson & Johnson Medical Devices Companies

shutterstock_1018079914
Cardio

Posted on 25.09.2019

Treating heart valve diseases needs collaboration

World Heart Day is approaching and it deserves to be highlighted that as patient advocates in the heart valve disease sector, our relationship with the medtech industry is as important as our partnership with the medical profession and the healthcare system. We base this relationship upon the ethos of innovation, information and independence. I see […]

By Wil Woan CEO of Heart Valve Voice

Fotolia_201695872_Subscription_Monthly_M
Cardio

Posted on 19.02.2019

Atrial fibrillation: The most understated disease of our time?

In 2019, and in every corner of the world, pressing issues affect patients and their way of life. Consequently, this impacts upon their loved ones and personal, professional and social communities. There are conditions and diseases that receive a lot of attention and are broadly recognised and there are those that don’t. Atrial fibrillation (AF,) […]

By Gabriele Fischetto Vice President Cardiovascular & Specialty Solutions, Johnson & Johnson Medical Devices EMEA